Leukotriene modifiers (leukotriene antagonists) are medicines used to manage allergic rhinitis or allergies, as well as prevent asthma. These novel drugs work by blocking the action of leukotrienes. They are not used as the first mode of treatment.
Leukotrienes are inflammatory chemicals the body releases after coming in contact with an allergen or allergy trigger. Leukotrienes cause tightening of airway muscles and the production of excess mucus and fluid. These chemicals play a key role in allergies, allergic rhinitis, and asthma, also causing a tightening of your airways, making it difficult to breathe.
For people who have allergies, the challenges of remaining physically active can easily outweigh the benefits to their health and mental well-being. Running, swimming, and even gardening -- how enjoyable can these activities be when just taking a breath is so exhausting?
But having seasonal allergies doesn't mean you have to become a shut-in. Nor does it mean, even in environments where pollen and other irritants are plentiful, that you have to give up exercise. "Allergies are not a disability,”...
Leukotriene modifiers work by blocking the action of leukotrienes, one cause of the inflammation and nasal congestion associated with allergies. For those with allergies and asthma, leukotriene modifiers help keep bronchial tubes, airways to your lungs, from constricting.
According to the American Academy of Allergy Asthma & Immunology, leukotriene modifiers can block both the early response to allergic triggers (sneezing and itching) as well as the delayed response to allergens that result in nasal congestion.
How are leukotriene modifiers used in treating asthma?
Leukotriene modifiers are also used to prevent asthma and exercise-induced asthma. These medicines should not be used alone to treat an acute asthma attack. Leukotriene modifiers decrease the body's production of the leukotrienes that worsen both asthma and allergic reactions.
Which leukotriene modifiers are recommended for allergies?
In a review of eight studies using montelukast, researchers confirmed that when compared to placebo, montelukast provided relief of symptoms that was similar to loratadine (Claritin), yet less relief than provided with nasal inhaled steroids. Intranasal steroids should be tried prior to any recommendation for leukotriene modifiers.